Literature DB >> 2816705

Adverse effects of cocaine on cardiovascular dynamics, myocardial blood flow, and coronary artery diameter in an experimental model.

S L Hale1, K J Alker, S Rezkalla, G Figures, R A Kloner.   

Abstract

Smoking "crack" is currently popular; this results in rapidly peaking, high blood levels of cocaine. Our purpose was to investigate the effects of rapid cocaine administration. Hemodynamics, myocardial blood flow, and left ventricular cavity end-systolic and end-diastolic areas were measured in pentobarbital-anesthetized dogs before and 15 minutes after (1) a bolus intravenous injection of cocaine (n = 6), or (2) a 10-minute infusion of cocaine (n = 6), or (3) saline (n = 6) administration. In both treated groups cocaine caused a significant reduction in heart rate and left ventricular dP/dt compared with baseline measurements, and an increase in left ventricular end-diastolic pressure. Cocaine also caused dilation of the left ventricle and a fall in regional myocardial blood flow. In nine other dogs, proximal circumflex artery diameter, assessed by angiography, and regional myocardial blood flow were measured before and 3 to 5 minutes after cocaine (n = 7) or saline (n = 2). In treated animals, circumflex artery diameter was reduced 15 +/- 4% (range 2% to 29%, p less than 0.01 versus baseline) after cocaine. We conclude that in this model, rapid administration of cocaine depresses left ventricular function, causes left ventricular dilation, and is associated with coronary artery vasoconstriction and reduced myocardial blood flow.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816705     DOI: 10.1016/0002-8703(89)90226-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

Review 1.  Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias.

Authors:  Michael E O'Leary; Jules C Hancox
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

2.  Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol.

Authors:  D Kenny; P S Pagel; D C Warltier
Journal:  Basic Res Cardiol       Date:  1992 Sep-Oct       Impact factor: 17.165

3.  Cocaine-induced vasoconstriction in the human coronary microcirculation: new evidence from myocardial contrast echocardiography.

Authors:  Swaminatha V Gurudevan; Michael D Nelson; Florian Rader; Xiu Tang; Joshua Lewis; Jimmy Johannes; J Todd Belcik; Robert M Elashoff; Jonathan R Lindner; Ronald G Victor
Journal:  Circulation       Date:  2013-06-28       Impact factor: 29.690

4.  Effects of cocaine on epicardial coronary artery reactivity in miniature swine after endothelial injury and high cholesterol feeding. In vivo and in vitro analysis.

Authors:  K Egashira; F S Pipers; J P Morgan
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

5.  Intraoperative pulmonary oedema in a young cocaine smoker.

Authors:  P P Singh; I Dimich; A Shamsi
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

Review 6.  Cocaine-induced acute myocardial infarction.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Clin Med Res       Date:  2007-10

7.  S100B protein expression in the heart of deceased individuals by overdose: a new forensic marker?

Authors:  Armando Faa; Giancarlo Senes; Annalisa Locci; Pietro Pampaloni; Maria Elena Pais; Bruno Piras; Ernesto d'Aloja; Gavino Faa
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

Review 8.  Beta Blocker Therapy in Heart Failure Patients with Active Cocaine Use: A Systematic Review.

Authors:  Baldeep K Mann; Janpreet S Bhandohal; Mohammad Saeed; Gerald Pekler
Journal:  Cardiol Res Pract       Date:  2020-05-08       Impact factor: 1.866

Review 9.  Acute and Chronic Effects of Cocaine on Cardiovascular Health.

Authors:  Sung Tae Kim; Taehwan Park
Journal:  Int J Mol Sci       Date:  2019-01-29       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.